ArticleCancer medicine2022

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).

Ticiana A Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.